Compass Therapeutics, Inc.CMPXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank29
3Y CAGR-4.3%
5Y CAGR-8.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-4.3%/yr
vs -11.7%/yr prior
5Y CAGR
-8.2%/yr
Recent acceleration
Acceleration
+7.4pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $30.64M | -29.5% |
| 2024 | $43.48M | +79.5% |
| 2023 | $24.23M | -30.7% |
| 2022 | $34.95M | -75.8% |
| 2021 | $144.51M | +207.0% |
| 2020 | $47.08M | +86.0% |
| 2019 | $25.30M | -56.0% |
| 2018 | $57.51M | - |